NASDAQ:BTAI | Profit Breakdown | BioXcel Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2017-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$182,000.00-$10.19M-$14.71M
2026-03-31$206,000.00-$10.22M-$12.69M
2025-12-31$256,000.00-$10.28M-$12.55M
2025-09-30$98,000.00-$14.23M-$30.91M
2025-06-30$120,000.00-$15.85M-$19.19M
2025-03-31$168,000.00-$10.1M-$7.25M
2024-12-31$366,000.00-$10.49M-$10.86M
2024-09-30$214,000.00-$15.29M-$13.65M
2024-06-30$1.1M-$17.3M-$8.3M
2024-03-31$582,000.00-$24.16M-$26.79M
2023-12-31$376,000.00-$19.88M-$22.26M
2023-09-30$341,000.00-$48.3M-$50.49M
2023-06-30$457,000.00-$52.41M-$53.52M
2023-03-31$206,000.00-$51.2M-$52.8M
2022-12-31$238,000.00-$52.89M-$54.81M
2022-09-30$137,000.00-$38.99M-$41.81M
2022-06-30-$36.29M-$37.67M
2022-03-31-$31.48M-$31.47M
2021-12-31-$26.13M-$26.13M
2021-09-30-$26.81M-$26.81M
2021-06-30-$27.61M-$27.62M
2021-03-31-$26.38M-$26.38M
2020-12-31-$21.1M-$21.09M
2020-09-30-$24.77M-$24.75M
2020-06-30-$21.44M-$21.42M
2020-03-31-$15M-$14.91M
2019-12-31-$8.41M-$8.28M
2019-09-30-$9.13M-$9.02M
2019-06-30-$8.64M-$8.47M
2019-03-31-$7.42M-$7.2M
2018-12-31-$7.31M-$7.08M
2018-09-30$0.00-$5.12M-$4.89M
2018-06-30$0.00-$3.24M-$3.03M
2018-03-31$0.00-$4.29M-$4.28M
2017-12-31-$2.53M-$2.53M
2017-09-30$0.00-$917,000.00-$917,000.00
2017-06-30$0.00-$565,000.00-$565,000.00
2017-03-31$0.00-$529,000.00-$529,000.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$642,000.00-$50.46M-$69.9M
2024-12-31$2.27M-$67.25M-$59.6M
2023-12-31$1.38M-$171.78M-$179.05M
2022-12-31$375,000.00-$159.65M-$165.76M
2021-12-31-$106.94M-$106.93M
2020-12-31-$82.3M-$82.17M
2019-12-31-$33.6M-$32.97M
2018-12-31-$19.96M-$19.27M
2017-12-31-$4.54M-$4.54M